The economic burden of adults with major depressive disorder in the United States (2005 and 2010).

@article{Greenberg2015TheEB,
  title={The economic burden of adults with major depressive disorder in the United States (2005 and 2010).},
  author={Paul E. Greenberg and Andree-Anne Fournier and Tammy Sisitsky and Crystal Pike and Ronald C. Kessler},
  journal={The Journal of clinical psychiatry},
  year={2015},
  volume={76 2},
  pages={
          155-62
        }
}
BACKGROUND The economic burden of depression in the United States--including major depressive disorder (MDD), bipolar disorder, and dysthymia--was estimated at $83.1 billion in 2000. [] Key MethodRESULTS The incremental economic burden of individuals with MDD increased by 21.5% (from $173.2 billion to $210.5 billion, inflation-adjusted dollars). The composition of these costs remained stable, with approximately 45% attributable to direct costs, 5% to suicide-related costs, and 50% to workplace costs. Only 38…

Figures and Tables from this paper

The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018)
TLDR
Although the total number of adults with MDD increased from 2010 to 2018, the incremental direct cost per individual declined, suggesting that substantial unmet treatment needs remain in this population.
The Increasing Economic Burden with Additional Steps of Pharmacotherapy in Major Depressive Disorder
TLDR
The economic burden among patients with MDD stratified by number of treatment lines needed for episode resolution was determined, with patients who completed treatment for their episode with a single line of antidepressant having the lowest total adjusted direct costs.
The economic burden of mental disorders in China, 2005–2013: implications for health policy
TLDR
A nation-wide strategic action plan for preventing mental disorders and promoting mental health and well-being is in urgent need to reduce the individual and societal costs of mental illnesses in China.
Major Depressive Disorder : Understanding Unmet Needs , Treatment Challenges , and Potential Implications of Pathways Beyond the Monoamine System
  • Psychology
  • 2018
Major depressive disorder (MDD) is a common mental health condition that affects more than 16% of adults in the United States. The incidence of MDD is highest in adults aged 18 to 25 years; an
The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States.
TLDR
TRD is associated with disproportionate health care costs and unemployment, suggesting potentially large economic and societal gains with effective management.
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
TLDR
Both anxious/distressed specifier and mixed-features specifier were associated with early onset, poor course and functioning, and suicidality in US adults, and much remains to be learned about the DSM-5 MDD specifiers in the general population.
The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States
TLDR
This analysis aims to estimate the 1- and 5-year cost-effectiveness of CBT versus SGA, along with overall uncertainty in the health economic consequences of each treatment, and to determine what additional evidence could reduce this uncertainty, thus better informing guidelines and policy surrounding depression treatment.
Economic burden of treatment-resistant depression among veterans in the United States
TLDR
Among US veterans, TRD poses a significant incremental economic burden relative to non-TRD MDD and non-MDD.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 35 REFERENCES
The economic burden of depression in 1990.
TLDR
Depression imposes significant annual costs on society, and the true burden of this illness may be even greater than is implied by the estimate.
The economic burden of depression in the United States: how did it change between 1990 and 2000?
TLDR
The economic burden of depression remained relatively stable between 1990 and 2000, despite a dramatic increase in the proportion of depression sufferers who received treatment.
Global burden of depressive disorders in the year 2000
TLDR
Depression is the fourth leading cause of disease burden, accounting for 4.4% of total DALYs in the year 2000, and it causes the largest amount of non-fatal burden, covering almost 12% of all total years lived with disability worldwide.
Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance
TLDR
MDD severity is significantly associated with increased treatment usage/costs, treatment adequacy, unemployment, and disability and with reduced work performance.
National trends in the treatment for depression from 1998 to 2007.
TLDR
Although there was little change in the proportion of patients receiving antidepressants, treatment with psychotherapy has declined, and rapid increases in depression treatment from 1987 to 1997 were followed by more modest increases during the following decade.
Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insurance.
TLDR
Patients with PTSD had higher rates of other mental health disorders (eg, anxiety and bipolar disorder) and higher mental health-related resource use and costs than control subjects with MDD in both Medicaid and privately insured populations.
Cost of lost productive work time among US workers with depression.
TLDR
The combined LPT burden among those with depression and the low level of treatment suggests that there may be cost-effective opportunities for improving depression-related outcomes in the US workforce.
A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996-2013.
TLDR
Treatment-resistant depression may present an annual added societal cost of $29-$48 billion, pushing up the total societal costs of major depression by as much as $106-$118 billion, and underscore the need for research on the mechanisms of depression, new therapeutic targets, existing and new treatment combinations, and tests to improve the efficacy of and adherence to treatments for treatment- resistant depression.
The impact of comorbidity of mental and physical conditions on role disability in the US adult household population.
TLDR
The staggering amount of health-related disability associated with mental and physical conditions should be considered in establishing priorities for the allocation of health care and research resources.
...
1
2
3
4
...